S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.07 (+0.87%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.30 (-1.79%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.07 (+0.87%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.30 (-1.79%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.07 (+0.87%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.30 (-1.79%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.07 (+0.87%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.30 (-1.79%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)

Eloxx Pharmaceuticals (ELOX) Competitors

$0.86
+0.06 (+8.11%)
(As of 03:45 PM ET)

ELOX vs. NSTGQ, WINT, SCNI, FNCH, KRBP, PKBO, TCBP, PALI, ALBT, and NSTG

Should you be buying Eloxx Pharmaceuticals stock or one of its competitors? The main competitors of Eloxx Pharmaceuticals include NanoString Technologies (NSTGQ), Windtree Therapeutics (WINT), Scinai Immunotherapeutics (SCNI), Finch Therapeutics Group (FNCH), Kiromic BioPharma (KRBP), Peak Bio (PKBO), TC Biopharm (TCBP), Palisade Bio (PALI), Avalon GloboCare (ALBT), and NanoString Technologies (NSTG). These companies are all part of the "biological products, except diagnostic" industry.

Eloxx Pharmaceuticals vs.

Eloxx Pharmaceuticals (NASDAQ:ELOX) and NanoString Technologies (NASDAQ:NSTGQ) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, community ranking, media sentiment, dividends, valuation, analyst recommendations and profitability.

Eloxx Pharmaceuticals presently has a consensus target price of $55.00, suggesting a potential upside of 6,258.38%. Given Eloxx Pharmaceuticals' higher possible upside, analysts plainly believe Eloxx Pharmaceuticals is more favorable than NanoString Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Eloxx Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
NanoString Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Eloxx Pharmaceuticals has higher earnings, but lower revenue than NanoString Technologies. Eloxx Pharmaceuticals is trading at a lower price-to-earnings ratio than NanoString Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eloxx PharmaceuticalsN/AN/A-$36.06M-$9.07-0.10
NanoString Technologies$127.26M0.05-$159.54M-$3.53-0.03

In the previous week, NanoString Technologies had 1 more articles in the media than Eloxx Pharmaceuticals. MarketBeat recorded 1 mentions for NanoString Technologies and 0 mentions for Eloxx Pharmaceuticals. Eloxx Pharmaceuticals' average media sentiment score of 0.92 beat NanoString Technologies' score of 0.00 indicating that Eloxx Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
Eloxx Pharmaceuticals Positive
NanoString Technologies Neutral

Eloxx Pharmaceuticals has a net margin of 0.00% compared to NanoString Technologies' net margin of -102.44%. Eloxx Pharmaceuticals' return on equity of 0.00% beat NanoString Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Eloxx PharmaceuticalsN/A N/A -203.00%
NanoString Technologies -102.44%-548.25%-53.79%

Eloxx Pharmaceuticals has a beta of 2.75, suggesting that its share price is 175% more volatile than the S&P 500. Comparatively, NanoString Technologies has a beta of 1.24, suggesting that its share price is 24% more volatile than the S&P 500.

8.6% of Eloxx Pharmaceuticals shares are owned by institutional investors. 20.2% of Eloxx Pharmaceuticals shares are owned by insiders. Comparatively, 3.1% of NanoString Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Eloxx Pharmaceuticals received 13 more outperform votes than NanoString Technologies when rated by MarketBeat users.

CompanyUnderperformOutperform
Eloxx PharmaceuticalsOutperform Votes
13
43.33%
Underperform Votes
17
56.67%
NanoString TechnologiesN/AN/A

Summary

Eloxx Pharmaceuticals beats NanoString Technologies on 10 of the 15 factors compared between the two stocks.


Get Eloxx Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELOX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELOX vs. The Competition

MetricEloxx PharmaceuticalsBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$2.72M$2.67B$4.90B$7.52B
Dividend YieldN/A2.37%2.88%3.86%
P/E Ratio-0.1027.24219.8416.60
Price / SalesN/A181.873,282.37201.55
Price / CashN/A29.1895.1454.73
Price / Book-0.184.364.474.54
Net Income-$36.06M-$6.09M$114.07M$211.39M
7 Day Performance-1.70%4.77%4.84%2.74%
1 Month Performance1.41%10.87%10.08%3.90%
1 Year Performance-73.05%11.15%12.30%8.08%

Eloxx Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NSTGQ
NanoString Technologies
0 of 5 stars
$0.05
-16.7%
N/AN/A$2.41M$127.26M-0.01550Gap Up
WINT
Windtree Therapeutics
1.319 of 5 stars
$0.33
-8.5%
N/A-94.3%$1.67MN/A-0.0220Short Interest ↓
News Coverage
Gap Up
SCNI
Scinai Immunotherapeutics
0 of 5 stars
$0.50
+4.2%
N/AN/A$938,000.00N/A-0.1533Short Interest ↑
News Coverage
Gap Up
FNCH
Finch Therapeutics Group
1.0008 of 5 stars
$2.42
-3.2%
$210.00
+8,577.7%
-78.3%$3.90M$860,000.00-0.0418Short Interest ↑
KRBP
Kiromic BioPharma
0 of 5 stars
$3.02
+2.7%
N/A-47.3%$3.90MN/A0.0031News Coverage
Gap Up
PKBO
Peak Bio
0 of 5 stars
$0.04
flat
N/AN/A$853,000.00$610,000.000.0021
TCBP
TC Biopharm
0.5603 of 5 stars
$1.16
+7.4%
$1,400.00
+120,589.7%
-99.8%$785,000.00$2.86M0.0060Short Interest ↑
PALI
Palisade Bio
3.7297 of 5 stars
$0.44
+2.3%
$8.75
+1,888.6%
-82.2%$4.08MN/A0.0012Short Interest ↓
Gap Up
ALBT
Avalon GloboCare
0 of 5 stars
$0.39
+2.6%
N/A-82.9%$4.29M$1.23M0.005
NSTG
NanoString Technologies
3.3398 of 5 stars
N/A$7.63
+∞
N/A$5.07M$127.26M-0.03550Analyst Report
Gap Down

Related Companies and Tools

This page (NASDAQ:ELOX) was last updated on 2/29/2024 by MarketBeat.com Staff